|
This is an index of adverse event reports related to Gemzar (Gemcitabine). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (436)
Cases resulting in a serious event (432)
Cases resulting in death (127)
Cases resulting in life threatening events (32)
Cases resulting in hospitalization (246)
Cases resulting in disability (27)
Cases resulting in other serious reactions (212)
Below is a sample of adverse event reports reports related to Gemzar (Gemcitabine). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in female receiving Gemzar (Gemcitabine)
Reported by a physician from Japan on 2007-10-31
Patient: female, weighing 47.0 kg (103.4 pounds)
Adverse reactions / side effects: Death, Cerebral Infarction, Haemolytic Uraemic Syndrome, Cerebral Haemorrhage
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Gemzar (Gemcitabine)
Adverse event in female receiving Gemzar (Gemcitabine)
Reported by a physician from China on 2007-10-31
Patient: female
Adverse reactions / side effects: Pulse Abnormal, Tachycardia, Extrasystoles, Chest Pain
Suspect drug(s):
Gemzar (Gemcitabine)
Other drugs received by patient: Fluorouracil; Isosorbide Mononitrate; Felodipine; Enalapril Maleate; Metoprolol
Adverse event in 74 year old male receiving Gemzar (Gemcitabine)
Reported by a physician from Japan on 2007-10-30
Patient: 74 year old male
Adverse reactions / side effects: Aortic Aneurysm Rupture
Adverse event resulted in: death
Suspect drug(s):
Gemzar (Gemcitabine)
Adverse event in 69 year old male receiving Gemzar (Gemcitabine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-30
Patient: 69 year old male
Adverse reactions / side effects: Gingival Bleeding, Tongue Haematoma, Sepsis, Pyrexia, Acute Respiratory Failure, Thrombocytopenia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Eloxatin
Indication: Pancreatic Carcinoma
Start date: 2007-07-26
End date: 2007-07-26
Gemzar
Indication: Pancreatic Carcinoma
Start date: 2007-07-26
End date: 2007-07-26
Ondansetron
Indication: Vomiting
Start date: 2007-07-26
End date: 2007-07-26
Solu-Medrol
Indication: Drug USE FOR Unknown Indication
Start date: 2007-07-26
End date: 2007-07-26
Adverse event in 45 year old female receiving Gemzar (Gemcitabine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-29
Patient: 45 year old female, weighing 64.4 kg (141.7 pounds)
Adverse reactions / side effects: Dyspnoea, Pneumonia, Disseminated Intravascular Coagulation, Pyrexia, Haemoglobin Decreased, Dysstasia, Respiratory Failure, Sepsis, Platelet Count Decreased, Asthenia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Gemzar
Dosage: 1000 mg/m2 (1780 mg) every two weeks
Indication: non-Small Cell Lung Cancer
Oxaliplatin
Dosage: 100 mg/m2 (178 mg) every two weeks
Indication: non-Small Cell Lung Cancer
Adverse event in 71 year old female receiving Gemzar (Gemcitabine)
Reported by a physician from Japan on 2007-10-26
Patient: 71 year old female
Adverse reactions / side effects: Anorexia, Dehydration
Adverse event resulted in: hospitalization
Suspect drug(s):
Gemzar
Dosage: 1000 mg/m2, other
Indication: Bile Duct Cancer
Start date: 2007-03-01
Gemzar
Dosage: 900 mg/m2, other
Start date: 2007-03-15
Adverse event in male receiving Gemzar (Gemcitabine)
Reported by a physician from Japan on 2007-10-26
Patient: male, weighing 55.0 kg (121.0 pounds)
Adverse reactions / side effects: Cataract, Dyspnoea, Urticaria, Benign Prostatic Hyperplasia, Pyrexia, Rash, Tricuspid Valve Incompetence, Pericardial Effusion, Haemoglobin Decreased, Renal Failure, Aortic Valve Incompetence
Adverse event resulted in: hospitalization
Suspect drug(s):
Gemzar (Gemcitabine)
Other drugs received by patient: Lendormin; Magnesium Oxide
Adverse event in 63 year old male receiving Gemzar (Gemcitabine)
Reported by a physician from Japan on 2007-10-26
Patient: 63 year old male
Adverse reactions / side effects: Disseminated Intravascular Coagulation, Endocarditis
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Gemzar (Gemcitabine)
Adverse event in male receiving Gemzar (Gemcitabine)
Reported by a physician from United States on 2007-10-26
Patient: male
Adverse reactions / side effects: Death, Pulmonary Oedema, Hypoxia, Haemolytic Uraemic Syndrome
Adverse event resulted in: death
Suspect drug(s):
Gemzar (Gemcitabine)
Adverse event in 72 year old male receiving Gemzar (Gemcitabine)
Reported by a physician from France on 2007-10-26
Patient: 72 year old male, weighing 73.0 kg (160.6 pounds)
Adverse reactions / side effects: Vertigo, Arteriosclerosis
Suspect drug(s):
Gemzar (Gemcitabine)
Other drugs received by patient: Skenan; Zestoretic; Kardegic; Inexium
Adverse event in female receiving Gemzar (Gemcitabine)
Reported by a physician from Japan on 2007-10-26
Patient: female, weighing 45.6 kg (100.3 pounds)
Adverse reactions / side effects: Haemolytic Uraemic Syndrome, Pericardial Effusion
Adverse event resulted in: hospitalization
Suspect drug(s):
Gemzar
Dosage: 1400 mg, unk
Indication: Yolk SAC Tumour Site Unspecified
Start date: 2007-06-21
End date: 2007-08-02
Gemzar
Dosage: 1400 mg, unk
Start date: 2007-07-05
End date: 2007-08-02
Gemzar
Dosage: 1000 mg, unk
Start date: 2007-07-19
End date: 2007-08-02
Gemzar
Dosage: 1000 mg, unk
Start date: 2007-08-02
End date: 2007-08-02
Other drugs received by patient: Elplat; Elplat; Elplat; Elplat; Kytril; Kytril; Kytril; Kytril; Decadron / NET /; Decadron / NET /; Decadron / NET /; Decadron / NET /; Baktar; Zovirax / GRC /; Diflucan
Adverse event in 77 year old male receiving Gemzar (Gemcitabine)
Reported by a physician from Germany on 2007-10-25
Patient: 77 year old male
Adverse reactions / side effects: Pulmonary Oedema, Cardiac Failure Acute, Thrombocytopenia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Gemzar
Dosage: 800 mg/m2, day 1,8 and 15 every 28 days
Indication: Pancreatic Carcinoma non-Resectable
Gemzar
Dosage: 1000 mg/m2, day 1,8 and 15 every 28 days
Other drugs received by patient: Mitomycin
Adverse event in 75 year old female receiving Gemzar (Gemcitabine)
Reported by a individual with unspecified qualification from Spain on 2007-10-25
Patient: 75 year old female
Adverse reactions / side effects: Cardiac Failure, Interstitial Lung Disease, Cardiovascular Insufficiency, Lactic Acidosis, Hepatitis, Pneumonitis
Adverse event resulted in: life threatening event
Suspect drug(s):
Gemzar
Dosage: 0 mg qd iv
Start date: 2005-08-31
End date: 2005-08-31
Navelbine
Dosage: 40 mg qd iv
Start date: 2005-08-31
End date: 2005-08-31
Adverse event in female receiving Gemzar (Gemcitabine)
Reported by a physician from Japan on 2007-10-25
Patient: female, weighing 52.0 kg (114.4 pounds)
Adverse reactions / side effects: Malignant Neoplasm Progression, Atrioventricular Block Complete, Disseminated Intravascular Coagulation, Acute Coronary Syndrome
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Gemzar (Gemcitabine)
Adverse event in 80 year old female receiving Gemzar (Gemcitabine)
Reported by a physician from United States on 2007-10-23
Patient: 80 year old female
Adverse reactions / side effects: Pneumonia, Thrombocytopenic Purpura, Pyrexia, Pulmonary Fibrosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Gemzar
Indication: Ovarian Cancer
Start date: 2006-01-01
Gemzar
Dosage: unk, unk
Start date: 2007-01-01
Adverse event in 65 year old male receiving Gemzar (Gemcitabine)
Reported by a physician from Japan on 2007-10-23
Patient: 65 year old male
Adverse reactions / side effects: Cholangitis, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Gemzar (Gemcitabine)
Adverse event in female receiving Gemzar (Gemcitabine)
Reported by a physician from United States on 2007-10-18
Patient: female, weighing 86.6 kg (190.6 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Cellulitis, Vomiting, Nausea, Alanine Aminotransferase Increased, Anaemia, Pain, Platelet Count Increased, Rash, Dehydration, Aspartate Aminotransferase Increased, Neutropenia, Blood Glucose Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Alimta
Dosage: 980 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2007-07-31
Gemzar
Dosage: 2000 mg, unk
Indication: non-Small Cell Lung Cancer
Start date: 2007-07-11
End date: 2007-07-17
Other drugs received by patient: Carboplatin; Cyclosporine; Folic Acid; Vitamin B-12; Dexamethasone 0.5mg TAB; Zocor; Potassium Chloride; Lasix; Zoloft; Ambien; Protonix / 01263201 /; Advair Diskus 100 / 50; Albuterol; Diovan; Antacid TAB
Adverse event in female receiving Gemzar (Gemcitabine)
Reported by a physician from United States on 2007-10-18
Patient: female, weighing 53.1 kg (116.7 pounds)
Adverse reactions / side effects: Vomiting, Nausea, Malignant Neoplasm Progression, Anaemia, Hypotension, Pyrexia, Hypokalaemia, Dehydration, Intervertebral Disc Degeneration, Pathological Fracture, Leukopenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Gemzar (Gemcitabine)
Other drugs received by patient: Procrit; Kytril; Aloxi; Zyrtec; Centrum; Ibuprin
Adverse event in 64 year old female receiving Gemzar (Gemcitabine)
Reported by a pharmacist from United States on 2007-10-18
Patient: 64 year old female, weighing 58.0 kg (127.6 pounds)
Adverse reactions / side effects: Rash Generalised, Skin Exfoliation, Rash Erythematous
Adverse event resulted in: hospitalization
Suspect drug(s):
Gemzar (Gemcitabine)
Adverse event in female receiving Gemzar (Gemcitabine)
Reported by a physician from Germany on 2007-10-17
Patient: female
Adverse reactions / side effects: Intussusception, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Eloxatin
Indication: Neoplasm Progression
Start date: 2007-09-28
End date: 2007-09-28
Gemzar
Start date: 2007-09-28
End date: 2007-09-28
Other drugs received by patient: Cotrim; Allopurinol
Adverse event in female receiving Gemzar (Gemcitabine)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-10-17
Patient: female
Adverse reactions / side effects: Dyspnoea, Pleural Effusion
Adverse event resulted in: hospitalization
Suspect drug(s):
Eloxatin
Indication: Neoplasm Progression
Start date: 2007-09-28
End date: 2007-09-28
Gemzar
Start date: 2007-09-28
End date: 2007-09-28
Adverse event in male receiving Gemzar (Gemcitabine)
Reported by a physician from France on 2007-10-16
Patient: male
Adverse reactions / side effects: Pleural Effusion, Generalised Oedema
Adverse event resulted in: hospitalization
Suspect drug(s):
Gemzar (Gemcitabine)
Adverse event in 56 year old female receiving Gemzar (Gemcitabine)
Reported by a physician from France on 2007-10-16
Patient: 56 year old female
Adverse reactions / side effects: Eyelid Oedema, Oedema Peripheral, Thrombocytopenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Gemzar (Gemcitabine)
Other drugs received by patient: Carboplatin
Adverse event in male receiving Gemzar (Gemcitabine)
Reported by a physician from France on 2007-10-16
Patient: male
Adverse reactions / side effects: Generalised Oedema
Adverse event resulted in: hospitalization
Suspect drug(s):
Gemzar (Gemcitabine)
Adverse event in female receiving Gemzar (Gemcitabine)
Reported by a physician from France on 2007-10-16
Patient: female
Adverse reactions / side effects: Generalised Oedema
Adverse event resulted in: hospitalization
Suspect drug(s):
Gemzar (Gemcitabine)
|
